A Multi‐Biomarker Disease Activity Score and the Choice of Second‐Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure
暂无分享,去创建一个
S. Saevarsdottir | I. Petersson | S. Ernestam | K. Hambardzumyan | R. V. van Vollenhoven | J. Wallman | R. Bolce | K. Forslind